Arginine vasopressin and baroreflex function after converting enzyme inhibition in normal humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 3 35-3, 1997, Pages

  Goldsmith, Steven R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

angiotensin converting enzyme inhibitor; neurohormones; norepinephrine kinetics; sympathetic nervous system

Indexed keywords

ARGIPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE; NORADRENALIN; PHENYLEPHRINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME INHIBITION; FOREARM BLOOD FLOW; HEART RATE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE; TILTING; VAGUS NERVE;

EID: 0030888379     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.3.e429     Document Type: Article

References (30)

1. Abboud, F. M., P. E. Aylward, J. S. Floras, and B. N. Gupta. Sensitization of aortic and cardiac baroreceptors by arginine vasopressin in mammals. J. Physiol. (Lond.) 377: 251-265, 1986.
2. Aylward, P. E., J. S. Flora, W. N. Leimbach, and F. M. Abboud. Effects of vasopressin on the circulation and its baroreflex control in healthy man. Circulation 73: 1145-1154, 1986.
3. Bennett, T., and S. M. Gardiner. Influence of exogenous vasopressin on baroreflex mechanisms. Clin. Sci. Lond. 70: 307-315, 1986.
4. Cowley, A. W., S. Switzer, and M. Guinn. Evidence and quantification of the vasopressin arterial control system in dogs. Circ. Res. 46: 58-67, 1980.
5. Ebert, T. J. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 7: 602-606, 1985.
6. Ebert, T. J., and A. W. Cowley. Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1372-H1378, 1992.
7. Ebert, T. J., and A. W. Cowley. Vasopressin reduces cardiac function and augments cardiopulmonary baroreceptor resistance increases in man. J. Clin. Invest. 77: 1136-1142, 1986.
8. Eckberg, D. L., R. F. Rea, O. K. Anderson, T. Hedner, J. Pernow, J. M. Lundberg, and B. G. Wallin. Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol. Scand. 133: 221-231, 1988.
9. Esler, M., G. Jackman, A. Bobik, D. Kellerher, G. Jennings, P. Leonard, H. Skews, and P. Korner. Determination of norepinephrine apparent spillover rate and clearance in humans. Life Sci. 25: 1461-1470, 1979.
10. Floras, J. S., P. E. Aylward, F. M. Abboud, and A. L. Mark. Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin. Hypertension 10: 409-416, 1987.
11. Goldsmith, S. R. Baroreceptor-mediated suppression of osmotically stimulated vasopressin in normal humans. J. Appl. Physiol. 65: 1226-1230, 1988.
12. Goldsmith, S. R. Physiological arginine vasopressin levels do not enhance baroreflex function in normal humans. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2374-H2379, 1994.
13. Goldsmith, S. R., A. W. Cowley, G. S. Francis, and J. N. Cohn. Effect of increased intracardiac and arterial pressure on plasma vasopressin in humans. Am. J. Physiol. 246 (Heart Circ. Physiol. 15): H647-H651, 1984.
14. Goldsmith, S. R., G. S. Francis, A. W. Cowley, and J. N. Cohn. Response of vasopressin and norepinephrine to lower body negative pressure in humans. Am. J. Physiol. 243 (Heart Circ. Physiol. 12): H970-H973, 1982.
15. Goldsmith, S. R., G. S. Francis, A. W. Cowley, T. B. Levine, and J. N. Cohn. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J. Am. Coll. Cardiol. 1: 1385-1390, 1983.
16. Goldsmith, S. R., and G. J. Hasking. Angiotensin II inhibits peripheral vascular responses to increased arterial pressure in humans. J. Am. Coll. Cardiol. 25: 246-250, 1995.
17. Goldsmith, S. R., and G. J. Hasking. Effect of a pressor infusion of angiotensin II on sympathetic activity and heart rate in normal humans. Circ. Res. 68: 263-268, 1991.
18. Guidicelli, J. F., A. Bordeaux, A. Edouard, C. Richer, and D. Jacolot. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br. J. Clin. Pharmacol. 20: 211-218, 1985.
19. Hasser, E. M., S. E. DiCarlo, R. J. Applegate, and V. S. Bishop. Osmotically released vasopressin augments cardiopulmonary reflex inhibition of the circulation. Am. J. Physiol. 254 (Regulatory Integrative Comp. Physiol. 23): R815-R820, 1988.
20. Hasser, E. M., K. P. Undesser, and V. S. Bishop. Interaction of vasopressin with area postrema during volume expansion. Am. J. Physiol. 253 (Regulatory Integrative Comp. Physiol. 22): R605-R610, 1987.
21. Hirsch, A., V. Dzau, J. Majzoub, and M. A. Creager. Vasopressin-mediatcd forearm vasodilation in normal humans. J. Clin. Invest. 84: 418-426, 1989.
22. Kondowe, G. B., A. H. Deering, J. G. Riddell, G. D. Johnston, and W. G. Harron. The effect of acute and chronic captopril therapy on baroreflex function in man. Br. J. Clin. Pharmacol. 25: 315-321, 1988.
23. Liard, J. F. Atropine potentiates the pressor effect of arginine vasopressin in conscious dogs. J. Cardiovasc. Pharmacol. 6: 867-871, 1984.
24. 3H]noradrenaline kinetics in man. Is separation of alumina extracts by high performance liquid chromatography necessary? Clin. Sci. Lond. 74: 151-154, 1988.
25. Mohring, J., K. Glanzen, and J. A. Maciel. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J. Cardiovasc. Pharmacol. 2: 367-376, 1980.
26. Montani, J. P., J. F. Liard, J. Schoun, and J. Mohring. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentration in conscious dogs. Circ. Res. 47: 346, 1980.
27. Panzenbeck, M. J., W. Tan, M. A. Hajdu, and I. H. Zucker. Prostaglandins mediate the increased sensitivity of left ventricular reflexes after captopril treatment in conscious dogs. J. Pharmacol. Exp. Ther. 244: 384-390, 1988.
28. Peuler, J. D., G. L. Edwards, P. G. Schmid, and A. K. Johnson. Area postrema and differential reflex effects of vasopressin and phenylephrine in rats. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H1255-H1259, 1990.
29. Serradeil-Le Gal, C., J. Wagnon, C. Garcia, C. Lacour, P. Guiraudou, B. Christophe, G. Villanova, D. Nisato, J. P. Maffrand, G. Le Fur, G. Guillon, B. Cantau, C. Barberis, M. Trueba, Y. Ala, and S. Jard. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin Via receptors. J. Clin. Invest. 92: 224-231, 1993.
30. Suzuki, S., A. Takeshita, T. Imaizumi, Y. Hirooka, M. Yoshida, S. Ando, and N. Nakamura. Central nervous system mechanisms involved in inhibition of renal sympathetic nerve activity induced by arginine vasopressin. Circ. Res. 65: 1390-1399, 1989.